Cargando…
Percutaneous Thermal Ablation for Renal Tumors in Patients with Birt–Hogg–Dubé Syndrome
SIMPLE SUMMARY: Percutaneous thermal ablation (TA) could be a safe and efficient nephron-sparing treatment for treating renal cell carcinoma (RCCs) associated with Birt–Hogg–Dubé (BHD) syndrome, a rare hereditary condition at greater risk of repeated treatments, even in the case of advanced chronic...
Autores principales: | Bodard, Sylvain, Boudhabhay, Idris, Dariane, Charles, Delavaud, Christophe, Guinebert, Sylvain, Joly, Dominique, Timsit, Marc-Olivier, Mejean, Arnaud, Verkarre, Virginie, Hélénon, Olivier, Richard, Stéphane, Correas, Jean-Michel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599652/ https://www.ncbi.nlm.nih.gov/pubmed/36291753 http://dx.doi.org/10.3390/cancers14204969 |
Ejemplares similares
-
Renal cell tumour characteristics in patients with the Birt-Hogg-Dubé cancer susceptibility syndrome: a retrospective, multicentre study
por: Benusiglio, Patrick R, et al.
Publicado: (2014) -
Birt–Hogg–Dubé syndrome
por: Daccord, Cécile, et al.
Publicado: (2020) -
Birt-Hogg-Dubé syndrome
por: Lencastre, André, et al.
Publicado: (2013) -
Birt‐Hogg‐Dubé syndrome in the elderly
por: Inoue, Masahide, et al.
Publicado: (2018) -
A Case of Birt-Hogg-Dubé Syndrome
por: Kim, En Hyung, et al.
Publicado: (2008)